Korean J Gastroenterol.  2023 Sep;82(3):154-156. 10.4166/kjg.2023.092.

Association of Anticoagulation and Survival in Patients with Cirrhosis and Portal Vein Thrombosis

• Yoon JH

• KMID: 2546519
• DOI: http://doi.org/10.4166/kjg.2023.092

Reference

1. Guerrero A, Campo LD, Piscaglia F, et al. 2023; Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis. J Hepatol. 79:69–78. DOI: 10.1016/j.jhep.2023.02.023. PMID: 36858157.

2. Anton A, Campreciós G, Pérez-Campuzano V, Orts L, García-Pagán JC, Hernández-Gea V. 2022; The pathophysiology of portal vein thrombosis in cirrhosis: Getting deeper into Virchow's triad. J Clin Med. 11:800. DOI: 10.3390/jcm11030800. PMID: 35160251. PMCID: PMC8837039.

3. Wang L, Guo X, Xu X, et al. 2021; Anticoagulation favors thrombus recanalization and survival in patients with liver cirrhosis and portal vein thrombosis: Results of a meta-analysis. Adv Ther. 38:495–520. DOI: 10.1007/s12325-020-01550-4. PMID: 33155180. PMCID: PMC7854392.